Publications

Mounho, B. Differences between small molecules and biological therapeutic drug products. Society of Toxicology. March 6-10, 2005. New Orleans, LA.

Perry, C.S., Garcia, S., Collie, S., MacDonell, M., Femi Adeshina, and Cynthia Sonich-Mullin: Application of provisional advisory levels for EPA National Homeland Security Research Center’s secure, internet-based rapid risk tool. Society for Risk Analysis’ Annual Meeting. December 4-7, 2005. Orlando, FL.

Urban, J.D. and R.B. Mailman. 2005. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting. November 12-16, 2005. Washington, DC.

Grasty RC, N Roberts, G Klinefelter, JA Bjork, KB Wallace, CS Lau, and JM Rogers (2005). Effects of prenatal perfluorooctanesulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res A Clin Mol Teratol 73: 314.

Haws, L. Roundtable: Is it Time to Reevaluate the Toxic Equivalency Factors for PCDDs, PCDFs, and Dioxin-Like PCBs? The Use of Toxicity Equivalence Factors (TEFs) for PCDDs, PCDFs, and Dioxin-Like PCBs in Risk Assessment: Improving the Process. Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, September 2004.

Haws L, Harris M, Su S, Walker N, Birnbaum L, DeVito M, Farland W, Connor K, Santamaria A, Finley B. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004, Berlin, Germany, September 2004.

Perry, C.S. and Morton, E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis’ Annual Meeting. December 5-8, 2004. Palm Springs, CA.

Staskal, D.F., J.J. Diliberto, M.J. DeVito, and L.S. Birnbaum. 2004. Tissue distribution and elimination of BDE 47 in mice following a single oral dose.  Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Staskal, D.F., J.J. Diliberto, M.J. DeVito, and L.S. Birnbaum. 2004. Disposition of 2,2’,4,4’-Tetrabromodiphenylether (BDE 47) in Female Mice. 43rd Annual Meeting of Society for Toxicology. March 21-25, 2004. Baltimore, MD.